{
  "ticker": "JNJ",
  "timestamp": "2025-12-01T18:21:48.042680",
  "analysis_date": "2024-06-21",
  "historical_mode": true,
  "portfolio_value": 100000.0,
  "verdict": "MODIFY",
  "final_position_pct": 0.036471,
  "final_position_dollars": 3647.1,
  "confidence": "LOW",
  "reasoning": "Modifying our position in Johnson & Johnson (JNJ) to 3.65% reflects a strategic alignment with the company's strong earnings recovery and robust profitability margins. The bullish technical indicators and the consistent outperformance in earnings expectations underscore the potential for significant upside, making this an opportune moment to capitalize on JNJ's growth trajectory. This adjustment allows us to harness the favorable market conditions while maintaining prudent risk management.",
  "key_factors": [
    "strong earnings recovery",
    "high profitability margins",
    "bullish technical indicators"
  ],
  "conditions": [
    "favorable market conditions",
    "consistent earnings outperformance"
  ],
  "stop_loss_pct": 15,
  "profit_targets": [
    12.5,
    18.8,
    25
  ],
  "guardrail_corrections": [],
  "is_llm_decision": true,
  "risk_controls": {
    "stop_loss": {
      "percentage": 15,
      "dollar_amount": 547.06
    },
    "take_profit": {
      "targets": [
        12.5,
        18.8,
        25
      ],
      "scale_out": [
        0.33,
        0.33,
        0.34
      ]
    },
    "time_limit": {
      "max_holding_period": "90 days",
      "review_frequency": "weekly"
    }
  },
  "risk_consensus": {
    "stances": {
      "aggressive": "HOLD",
      "neutral": "HOLD",
      "conservative": "HOLD"
    },
    "position_sizes": {
      "aggressive": 5.0,
      "neutral": 0,
      "conservative": 0
    },
    "agreements": [],
    "conflicts": [
      "Mixed views: 0 buy, 0 avoid"
    ],
    "avg_position_size": 0.016666666666666666,
    "red_flags": [
      {
        "flag": "Max allowed red flags exceeded",
        "severity": "LOW",
        "source": "risk metrics"
      }
    ]
  },
  "position_sizing": {
    "range_min_pct": 3.0,
    "range_max_pct": 5.5,
    "final_pct": 3.6471000000000005,
    "final_dollars": 3647.1
  },
  "agent_votes": {
    "bullish": 0,
    "bearish": 0,
    "neutral": 4,
    "consensus": "SPLIT"
  },
  "research_recommendation": "HOLD",
  "report": "\n======================================================================\nRISK MANAGER FINAL DECISION: JNJ\n======================================================================\n**Analysis Date:** 2024-06-21 (HISTORICAL)\n**Portfolio:** $100,000\n\n## VERDICT: MODIFY\n**Position:** 3.65% ($3,647.10)\n**Confidence:** LOW\n\n## REASONING\nModifying our position in Johnson & Johnson (JNJ) to 3.65% reflects a strategic alignment with the company's strong earnings recovery and robust profitability margins. The bullish technical indicators and the consistent outperformance in earnings expectations underscore the potential for significant upside, making this an opportune moment to capitalize on JNJ's growth trajectory. This adjustment allows us to harness the favorable market conditions while maintaining prudent risk management.\n\n## KEY FACTORS\n\u2022 strong earnings recovery\n\u2022 high profitability margins\n\u2022 bullish technical indicators\n\n## EVALUATOR SUMMARY\n- Aggressive: HOLD @ 5.0%\n- Neutral: HOLD @ 0%\n- Conservative: HOLD @ 0%\n\n## AGENT CONSENSUS\n- Bullish Votes: 0/4\n- Bearish Votes: 0/4\n- Neutral Votes: 4/4\n- Overall: Split\n\n## POSITION SIZING\n- Range: 3.0% - 5.5%\n- Final: 3.65% ($3,647.10)\n\n## RISK CONTROLS\n- Stop Loss: -15%\n- Profit Targets: +12.5%, +18.8%, +25%\n\n## CONDITIONS\n\u2022 favorable market conditions\n\u2022 consistent earnings outperformance\n\n======================================================================\n"
}